India Cements (INDIACEM)

FairStock Score: 50/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I am looking at India Cements as a cement cyclical, not a compounder. At ₹375.30, the market cap is ₹17,446 Cr, while book value is ₹326.70, so P/B is 1.15. That is the most Graham-ish number here: I am not paying a huge premium to accounting net worth. But the business is not earning. ROE is -1.10%, ROCE is -5.49%, and the latest quarter had sales of ₹1,114 Cr with a net loss of ₹3 Cr. P/E of 125.10 and EV/EBITDA of 220.40 tell me earnings are near zero, so those multiples are not useful. Sales growth is -0.50%, and five-year revenue CAGR is -4.36%; this is not growth. The positive is a debt/equity of 0.13 and FCF of ₹1,759 Cr, so the balance sheet is not stretched and cash generation exists despite weak profits. Promoter holding is 75%, which gives skin in the game, but dividend yield is zero. Piotroski 6/9 is mixed, and Altman Z-score 1.65 suggests financial risk. The DCF intrinsic value of ₹3037.60 looks alluring, but I would not trust it when ROCE is negative and EV/EBITDA is 220.40; it likely assumes a sharp cement-cycle recovery. The 52-week range of ₹287.60–₹485.80 shows volatility. FairStock 50/100 confirms mixed quality. Cement has no durable moat—product is commodity, pricing is cyclical. I would call this a cyclical with asset support, not a Buffett stalwart. At P/B 1.15, downside may be limited, but I want evidence of positive ROCE, stable sales, and real profits before paying ₹375.30.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer